Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

NCT00608907

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hematology Institute - Davidoff Center - Rabin Medical Center Petah Tikva, Israel
  • Divisione di Ematologia - Ospedale S Eugenio - P. le dell'Umanesimo Rome, Italy
  • Medical Academy - Dept of Hematology and Transplantology Gdansk, Poland
  • Klinika Nowotworow Ukladu - Chlonnego - Centrum Onkologii - Instytut Warsaw, Poland
View Trial Details
Completed

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

NCT00501735

Conditions
Cutaneous T-cell Lymphoma (CTCL),, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Alabama at Birmingham, Comprehensive Cancer Ctr Birmingham, Alabama, United States
  • Stanford University Medical Center Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 41 locations
View Trial Details
Completed

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

NCT00640523

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Indiana University Cancer Pavillion Indianapolis, Indiana, United States
  • Center for Cancer & Blood Disorders, PC Bethesda, Maryland, United States
View Trial Details

Related conditions